Cutting edge: Identification of hepatitis C virus-specific CD8+ T cells restricted by donor HLA alleles following liver transplantation

Hugo R. Rosen, David J. Hinrichs, Rachel L. Leistikow, Glenda Callender, Anne M. Wertheimer, Michael I. Nishimura, David M. Lewinsohn

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

By necessity, human liver transplantation is performed across HLA barriers. As a result, intracellular infection of the allograft presents a unique immunologic challenge for the recipient's immune system. In this study, we describe the presence of HLA-A2-restricted, hepatitis C virus (HCV)-specific CD8+ T cells in liver transplant recipients in whom the allograft is HLA-A2 positive and the recipient is HLA-A2 negative. These memory-effector T cells are recipient derived and recognize HCV peptide uniquely in the context of HLA-A2. Furthermore, these cells were absent before the transplant, suggesting that the allograft is capable of selectively expanding naive CD8+ T cells. The in vitro specificity to donor HLA allele-restricted CD8+ T cells suggests that these cells may function to control HCV spread in the allograft.

Original languageEnglish (US)
Pages (from-to)5355-5359
Number of pages5
JournalJournal of Immunology
Volume173
Issue number9
DOIs
StatePublished - Nov 1 2004

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Cutting edge: Identification of hepatitis C virus-specific CD8<sup>+</sup> T cells restricted by donor HLA alleles following liver transplantation'. Together they form a unique fingerprint.

  • Cite this